vs

Side-by-side financial comparison of CME Group (CME) and DANA Inc (DAN). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.3B, roughly 1.5× DANA Inc). CME Group runs the higher net margin — 0.1% vs -3.9%, a 3.9% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs -44.5%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -31.2%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Dana Incorporated is an American supplier of axles, driveshafts, and electrodynamic, thermal, sealing, and digital equipment for conventional, hybrid, and electric-powered vehicles. The company's products and services are aimed at the light vehicle and commercial vehicle equipment markets. Founded in 1904 and based in Maumee, Ohio, the company employs nearly 28,000 people in 33 countries. In 2022, Dana generated sales of $10.2 billion. The company is included in the Fortune 500.

CME vs DAN — Head-to-Head

Bigger by revenue
CME
CME
1.5× larger
CME
$1.9B
$1.3B
DAN
Growing faster (revenue YoY)
CME
CME
+59.0% gap
CME
14.5%
-44.5%
DAN
Higher net margin
CME
CME
3.9% more per $
CME
0.1%
-3.9%
DAN
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
-31.2%
DAN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CME
CME
DAN
DAN
Revenue
$1.9B
$1.3B
Net Profit
$1.2M
$-50.0M
Gross Margin
6.0%
Operating Margin
0.1%
-0.2%
Net Margin
0.1%
-3.9%
Revenue YoY
14.5%
-44.5%
Net Profit YoY
20.7%
37.5%
EPS (diluted)
$-0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
DAN
DAN
Q1 26
$1.9B
Q4 25
$1.6B
$1.3B
Q3 25
$1.5B
$1.9B
Q2 25
$1.7B
$1.9B
Q1 25
$1.6B
$2.4B
Q4 24
$1.5B
$2.3B
Q3 24
$1.6B
$2.5B
Q2 24
$1.5B
$2.7B
Net Profit
CME
CME
DAN
DAN
Q1 26
$1.2M
Q4 25
$1.2B
$-50.0M
Q3 25
$908.0M
$83.0M
Q2 25
$1.0B
$27.0M
Q1 25
$956.2M
$25.0M
Q4 24
$874.6M
$-80.0M
Q3 24
$912.8M
$4.0M
Q2 24
$883.2M
$16.0M
Gross Margin
CME
CME
DAN
DAN
Q1 26
Q4 25
6.0%
Q3 25
8.7%
Q2 25
7.1%
Q1 25
9.4%
Q4 24
5.7%
Q3 24
9.9%
Q2 24
9.3%
Operating Margin
CME
CME
DAN
DAN
Q1 26
0.1%
Q4 25
61.8%
-0.2%
Q3 25
63.3%
2.8%
Q2 25
66.7%
0.8%
Q1 25
67.5%
3.1%
Q4 24
62.1%
-1.5%
Q3 24
64.6%
3.6%
Q2 24
65.3%
3.8%
Net Margin
CME
CME
DAN
DAN
Q1 26
0.1%
Q4 25
71.7%
-3.9%
Q3 25
59.1%
4.3%
Q2 25
60.6%
1.4%
Q1 25
58.2%
1.1%
Q4 24
57.3%
-3.4%
Q3 24
57.6%
0.2%
Q2 24
57.6%
0.6%
EPS (diluted)
CME
CME
DAN
DAN
Q1 26
Q4 25
$3.24
$-0.36
Q3 25
$2.49
$0.64
Q2 25
$2.81
$0.19
Q1 25
$2.62
$0.17
Q4 24
$2.40
$-0.55
Q3 24
$2.50
$0.03
Q2 24
$2.42
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
DAN
DAN
Cash + ST InvestmentsLiquidity on hand
$2.4B
$469.0M
Total DebtLower is stronger
$3.4B
$2.6B
Stockholders' EquityBook value
$840.0M
Total Assets
$202.0B
$7.8B
Debt / EquityLower = less leverage
3.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
DAN
DAN
Q1 26
$2.4B
Q4 25
$4.5B
$469.0M
Q3 25
$2.6B
$414.0M
Q2 25
$2.1B
$486.0M
Q1 25
$1.5B
$507.0M
Q4 24
$3.0B
$494.0M
Q3 24
$2.4B
$419.0M
Q2 24
$1.9B
$419.0M
Total Debt
CME
CME
DAN
DAN
Q1 26
$3.4B
Q4 25
$2.6B
Q3 25
$2.6B
Q2 25
$2.6B
Q1 25
$2.4B
Q4 24
$2.4B
Q3 24
$2.4B
Q2 24
$2.4B
Stockholders' Equity
CME
CME
DAN
DAN
Q1 26
Q4 25
$28.7B
$840.0M
Q3 25
$28.2B
$1.1B
Q2 25
$27.7B
$1.2B
Q1 25
$27.0B
$1.4B
Q4 24
$26.5B
$1.3B
Q3 24
$28.2B
$1.5B
Q2 24
$27.6B
$1.5B
Total Assets
CME
CME
DAN
DAN
Q1 26
$202.0B
Q4 25
$198.4B
$7.8B
Q3 25
$187.1B
$8.1B
Q2 25
$179.9B
$8.1B
Q1 25
$157.8B
$7.8B
Q4 24
$137.4B
$7.5B
Q3 24
$137.8B
$7.9B
Q2 24
$123.4B
$7.8B
Debt / Equity
CME
CME
DAN
DAN
Q1 26
Q4 25
3.05×
Q3 25
2.35×
Q2 25
2.13×
Q1 25
1.76×
Q4 24
1.79×
Q3 24
1.65×
Q2 24
1.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
DAN
DAN
Operating Cash FlowLast quarter
$406.0M
Free Cash FlowOCF − Capex
$345.0M
FCF MarginFCF / Revenue
26.6%
Capex IntensityCapex / Revenue
4.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$298.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
DAN
DAN
Q1 26
Q4 25
$1.1B
$406.0M
Q3 25
$968.1M
$111.0M
Q2 25
$1.1B
$32.0M
Q1 25
$1.1B
$-37.0M
Q4 24
$1.0B
$302.0M
Q3 24
$1.0B
$35.0M
Q2 24
$776.9M
$215.0M
Free Cash Flow
CME
CME
DAN
DAN
Q1 26
Q4 25
$1.1B
$345.0M
Q3 25
$949.7M
$62.0M
Q2 25
$1.0B
$3.0M
Q1 25
$1.1B
$-112.0M
Q4 24
$991.7M
$149.0M
Q3 24
$973.2M
$-11.0M
Q2 24
$758.7M
$104.0M
FCF Margin
CME
CME
DAN
DAN
Q1 26
Q4 25
66.8%
26.6%
Q3 25
61.8%
3.2%
Q2 25
61.5%
0.2%
Q1 25
67.1%
-4.8%
Q4 24
65.0%
6.4%
Q3 24
61.4%
-0.4%
Q2 24
49.5%
3.8%
Capex Intensity
CME
CME
DAN
DAN
Q1 26
Q4 25
2.0%
4.7%
Q3 25
1.2%
2.6%
Q2 25
1.1%
1.5%
Q1 25
0.9%
3.2%
Q4 24
1.7%
6.6%
Q3 24
1.9%
1.9%
Q2 24
1.2%
4.1%
Cash Conversion
CME
CME
DAN
DAN
Q1 26
Q4 25
0.96×
Q3 25
1.07×
1.34×
Q2 25
1.03×
1.19×
Q1 25
1.17×
-1.48×
Q4 24
1.16×
Q3 24
1.10×
8.75×
Q2 24
0.88×
13.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

DAN
DAN

Light Vehicle Segment$912.0M70%
Commercial Vehicle Segment$218.0M17%
Other$166.0M13%

Related Comparisons